Stock Research: OPKO Health

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

OPKO Health

NasdaqGS:OPK US68375N1037
30
  • Value
    70
  • Growth
    13
  • Safety
    Safety
    51
  • Combined
    30
  • Sentiment
    39
  • 360° View
    360° View
    30
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. It operates in pharmaceutical and diagnostics industries, with key pharmaceutical products like Somatrogon (NGENLA) and Rayaldee, and clinical laboratory operations through BioReference. Its pharmaceutical operations are in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, and the United States. In the last fiscal year, the company had a market cap of $1071 millions, profits of $219 millions, revenue of $713 millions, and 2997 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 30 (better than 30% compared with alternatives), overall professional sentiment and financial characteristics for the stock OPKO Health are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for OPKO Health. The consolidated Value Rank has an attractive rank of 51, which means that the share price of OPKO Health is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 51% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 70. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 39. Professional investors are more confident in 61% other stocks. The consolidated Growth Rank also has a low rank of 13, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 87 of its competitors have better growth. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
51 41 44 18
Growth
13 57 67 1
Safety
Safety
70 86 49 61
Sentiment
39 49 42 13
360° View
360° View
30 77 38 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
95 95 95 95
Opinions Change
50 50 50 50
Pro Holdings
n/a 51 44 3
Market Pulse
4 10 7 4
Sentiment
39 49 42 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
51 41 44 18
Growth
13 57 67 1
Safety Safety
70 86 49 61
Combined
30 82 10 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 1 1 1
Price vs. Earnings (P/E)
36 23 31 25
Price vs. Book (P/B)
74 84 85 79
Dividend Yield
1 1 1 1
Value
51 41 44 18
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
14 10 6 1
Profit Growth
1 76 80 38
Capital Growth
42 28 75 4
Stock Returns
43 93 85 63
Growth
13 57 67 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
69 85 82 80
Refinancing
92 94 43 45
Liquidity
9 9 15 40
Safety Safety
70 86 49 61

Similar Stocks

Discover high‑ranked alternatives to OPKO Health and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.